Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Topics
»
Disease categories and therapies
» Nephrology
Nephrology
RSS
McGill University researchers improve safety of cell therapy
Aug. 23, 1996
Bioniche seeks U.S. approval to begin Cystistat clinical trials
Aug. 23, 1996
Boston Scientific to distribute Urologix technology
Aug. 23, 1996
EDAP signs license agreement for microwave technology
Aug. 23, 1996
U.S. patent granted for (S)-oxybutynin
Aug. 16, 1996
Sepracor to develop (S)-doxazosin for BPH; U.S. patent granted
Aug. 16, 1996
Leiras claims oral delivery system for oxybutynin chloride
July 26, 1996
Novo Nordisk claims xanomeline as potential urinary bladder disorder treatment
July 26, 1996
Positive results in trial of Cystistat in refractory interstitial cystitis patients
July 19, 1996
CGP-53153: Ciba-Geigy's steroidal 5alpha-reductase inhibitor as BPH therapy
July 19, 1996
Previous
1
2
…
321
322
323
324
325
326
327
328
329
330
Next
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe